FRAILTY SYNDROME IN CLINICAL NEUROLOGY: A COMPREHENSIVE REVIEW OF NERVOUS SYSTEM PATHOPHYSIOLOGY, PROGNOSIS IN SELECTED CONDITIONS, AND SOCIO-TECHNOLOGICAL PERSPECTIVES
Authors:
- Katarzyna MichtaKMKatarzyna Michta
- Zuzanna LechowskaZLZuzanna Lechowska
- Zuzanna KafaraZKZuzanna Kafara
- Agnieszka KafaraAKAgnieszka Kafara
- Dominika JurczakDJDominika Jurczak
- Julia Koronczok-MatusiakJKJulia Koronczok-Matusiak
- Donata KowalczykDKDonata Kowalczyk
- Wiktoria KrólWKWiktoria Król
- Konrad KulkaKKKonrad Kulka
- Rafał SzarekRSRafał Szarek
Open Access
- 2 July 2026
- journal article
- review article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
Abstract
Background: Neurological conditions are now the leading cause of disability worldwide. Frailty syndrome, defined as a multisystemic state of physiological impairment, often predicts clinical outcomes more accurately than chronological age. Objective: This review examines the molecular pathophysiology of neuro-frailty, its prognostic significance in acute ischemic stroke, multiple sclerosis (MS), and Parkinson’s disease (PD), as well as the integration of emerging diagnostic technologies. Methodology: A comprehensive review of English-language articles published from 2001 to 2026 in PubMed, Scopus, and Cochrane was conducted. Grey literature and animal studies were excluded from the analysis. The synthesis focused on meta-analyses and human-based research connecting artificial intelligence diagnostics, fluid biomarkers, and clinical neurology. Results: Neuro-frailty is associated with the phenomenon of inflammaging, the secretory ageing-associating phenotype (SASP), and progressive mitochondrial dysfunction. The presence of pre-existing frailty also elevates the risk of unfavorable functional recovery (mRS > 2) in acute phase of ischaemic stroke by 3.11 times. In MS, ongoing neurodegeneration accelerates biological ageing, often resulting in premature frailty. The sarcopenia-frailty axis in Parkinson’s disease affects over 35% of patients and significantly increases the risk of recurrent falls. Modern diagnostic methods now enable objective and precise quantification of this impairment. Conclusions: Frailty is a dynamic clinical condition that is possible to reverse. The transition from age-based metrics to AI-powered biological screening enables a personalized approach to care by clinicians. These targeted strategies are essential for maintaining neurological functions and reducing socio-economic consequences of ageing.Keywords
This publication has 34 references indexed in Scilit:
- Assessment of sarcopenia tools as predictors of falls in patients with mild to moderate Parkinson's Disease: A cohort studyClinics, 2025
- Cost of illness analysis of frailty for older adults: a systematic review and meta-analysisEuropean Geriatric Medicine, 2024
- Advances of artificial intelligence in predicting frailty using real-world data: A scoping reviewAgeing Research Reviews, 2024
- Association between pre-stroke frailty status and stroke risk and impact on outcomes: a systematic review and meta-analysis of 1,660,328 participantsAging Clinical and Experimental Research, 2024
- Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet Neurology, 2024
- Prevalence and Risk Factors of Frailty in Stroke Patients: A Meta-Analysis and Systematic ReviewThe Journal of nutrition, health and aging, 2023
- Frailty and Cognitive Function in Older Adults: A Systematic Review and Meta-Analysis of Cross-Sectional StudiesNeuropsychology Review, 2021
- The global burden of neurological disorders: translating evidence into policyThe Lancet Neurology, 2020
- The senescence-associated secretory phenotype and its regulationCytokine, 2019
- Hypothalamic‐Pituitary‐Adrenal (HPA) Axis and AgingComprehensive Physiology, 2014